Skip to content
Search

Latest Stories

Labour sweeps to power, Wes Streeting MP appointed as new health secretary

Labour sweeps to power, Wes Streeting MP appointed as new health secretary

Pharmacies bodies are pleased with Wes Streeting’s acknowledgment of the critical pharmacy funding pressures and his plans for primary care reform

Wes Streeting MP has been appointed Secretary of State for Health and Social Care in the new Labour Government.

The Ilford North MP will now take on the critical role of overseeing the National Health Service (NHS) and implementing Labour's ambitious health agenda.


At the core of the Labour Party’s healthcare reform manifesto is enhancing accessibility to primary and community healthcare.  This involves implementing a ‘Community Pharmacist Prescribing Service,’ to empower pharmacists with independent prescribing rights where clinically suitable.

This initiative aims to alleviate the strain on GP practices and enhance service accessibility.

Additionally, the manifesto proposes piloting Neighbourhood Health Centres, to integrate various healthcare services —such as family doctors, district nurses, and mental health specialists under one roof.

Streeting has recognised the pressing funding challenges faced by pharmacies and shown support for the sector during his campaign.

Commenting on Streeting’s appointment as new Health and Social Care Secretary, Community Pharmacy England (CPE) Chief Executive, Janet Morrison, said: “We would like to welcome the new Secretary of State to his role.

“We worked with Wes and his policy advisors whilst they were in Opposition, and have been encouraged by his recognition of the critical pharmacy funding pressures and support for the sector on the campaign trail.”

CPE is looking forward to “further strengthening Wes’ connection with community pharmacy and to working constructively with him and his colleagues to secure a sustainable future for community pharmacy that also supports the new Government’s health ambitions.”

She added that early discussions with the new government will be aimed at ensuring the future of this critical local healthcare network including finalizing negotiations for the 2024/25 Community Pharmacy Contractual Framework (CPCF) and exploring Labour’s interest in developing a community pharmacy prescribing service.

The Company Chemists’ Association (CCA) is supportive of Streeting’s plans for primary care reform, including the establishment of a ‘Community Pharmacist Prescribing Service’.

Malcolm Harrison, Chief Executive of the CCA said: “We congratulate Wes Streeting on his appointment as Secretary of State for Health and Social Care.

“We are encouraged by Mr. Streeting’s plans for primary care reform and welcome further detail on plans to create a ‘Community Pharmacist Prescribing Service’ and the granting of prescribing rights to pharmacists.”

He noted that community pharmacy is “absolutely integral” to realising the Secretary of State’s vision for primary care – whether that’s the return of the ‘family doctor’, embedding a greater focus on prevention in the NHS, or delivering more and more care closer to people’s homes.”

He added that the sector is ready and willing to delivering this vision but this can only be done “if there is adequate funding to ensure that patients can continue to access the medicines they need.”

“Moreover, pharmacies can do so much more to free up GP capacity, particularly through the expansion of Pharmacy First – but this is only possible through additional investment.”

As reported by Sky News, Wes Streeting studied history at Cambridge University, where he actively participated in student politics. He became the president of the National Union of Students in 2008, at the age of 25.

After his time in student politics, he worked for a Labour-affiliated think tank. In 2010, he was elected as a Labour councillor in Redbridge, East London.

Following five years in local politics, Streeting was elected to the House of Commons in 2015, after winning the seat of Ilford North, the area where he had served as a councillor.

Streeting campaigned for the UK to remain in the European Union in 2016 and was re-elected to the Commons with an increased majority in 2017. After Labour's defeat in the 2019 general election, Jeremy Corbyn resigned, and Sir Keir Starmer took over as party leader.

In April 2020, Streeting joined the party's frontbench as shadow exchequer secretary to the Treasury. By the end of the year, he was appointed shadow schools minister, and in May 2021, he was promoted to the shadow cabinet as the shadow secretary of state for child poverty, a role created for him and later abolished.

In November 2021, Streeting was appointed shadow health secretary.

Sir Keir Starmer has become the new Prime Minister following his Labour Party's landslide victory, marking their return to power after over a decade in opposition.

In his inaugural speech outside 10 Downing Street, Starmer said he would lead a “government of service” on a mission of national renewal.

With results declared for all but two seats, Labour secured 412 seats in the 650-seat House of Commons, while the Conservatives obtained 121 seats.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less